|4Feb 28, 4:00 PM ET

Barclay Alec 4

4 · T2 Biosystems, Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2022-02-24
Barclay Alec
SVP, Operations
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-02-24168,488336,976 total
    Common Stock (168,488 underlying)
  • Exercise/Conversion

    Common Stock

    2021-02-24+168,488247,633 total
  • Tax Payment

    Common Stock

    2021-02-24$0.45/sh88,878$39,888158,755 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]88,878 shares of common stock were automatically withheld at vesting to cover required tax withholding.
  • [F3]On February 24, 2021 the reporting person was granted 505,464 RSU's that vest in three equal annual installments commencing on February 24, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION